Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
10.73
-0.54 (-4.79%)
At close: Dec 12, 2025, 4:00 PM EST
10.94
+0.21 (1.96%)
After-hours: Dec 12, 2025, 5:45 PM EST
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $148.66 million as of December 12, 2025. Its market cap has decreased by -21.19% in one year.
Market Cap
148.66M
Enterprise Value
144.85M
1-Year Change
-21.19%
Ranking
Category
Stock Price
$10.73
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $148.66M, an increase of 116.43%. That is a compound annual growth rate of 15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 148.66M | 0.71% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |